Literature DB >> 25599482

Choosing between methods to prevent methicillin-resistant Staphylococcus aureus in ICUs*.

Daniel J Morgan1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25599482      PMCID: PMC4299917          DOI: 10.1097/CCM.0000000000000779

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  13 in total

1.  Screening inpatients for MRSA--case closed.

Authors:  Michael B Edmond; Richard P Wenzel
Journal:  N Engl J Med       Date:  2013-05-29       Impact factor: 91.245

2.  Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit.

Authors:  Adrian G Barnett; Rahul Batra; Nicholas Graves; Jonathan Edgeworth; Julie Robotham; Ben Cooper
Journal:  Am J Epidemiol       Date:  2009-09-17       Impact factor: 4.897

3.  Methicillin-resistant Staphylococcus aureus prevention strategies in the ICU: a clinical decision analysis*.

Authors:  Panayiotis D Ziakas; Ioannis M Zacharioudakis; Fainareti N Zervou; Eleftherios Mylonakis
Journal:  Crit Care Med       Date:  2015-02       Impact factor: 7.598

4.  Effect of daily chlorhexidine bathing on hospital-acquired infection.

Authors:  Michael W Climo; Deborah S Yokoe; David K Warren; Trish M Perl; Maureen Bolon; Loreen A Herwaldt; Robert A Weinstein; Kent A Sepkowitz; John A Jernigan; Kakotan Sanogo; Edward S Wong
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

5.  National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011.

Authors:  Raymund Dantes; Yi Mu; Ruth Belflower; Deborah Aragon; Ghinwa Dumyati; Lee H Harrison; Fernanda C Lessa; Ruth Lynfield; Joelle Nadle; Susan Petit; Susan M Ray; William Schaffner; John Townes; Scott Fridkin
Journal:  JAMA Intern Med       Date:  2013-11-25       Impact factor: 21.873

6.  Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.

Authors:  Anthony D Harris; Lisa Pineles; Beverly Belton; J Kristie Johnson; Michelle Shardell; Mark Loeb; Robin Newhouse; Louise Dembry; Barbara Braun; Eli N Perencevich; Kendall K Hall; Daniel J Morgan; Syed K Shahryar; Connie S Price; Joseph J Gadbaw; Marci Drees; Daniel H Kett; L Silvia Muñoz-Price; Jesse T Jacob; Loreen A Herwaldt; Carol A Sulis; Deborah S Yokoe; Lisa Maragakis; Matthew E Lissauer; Marcus J Zervos; David K Warren; Robin L Carver; Deverick J Anderson; David P Calfee; Jason E Bowling; Nasia Safdar
Journal:  JAMA       Date:  2013-10-16       Impact factor: 56.272

Review 7.  Chlorhexidine: expanding the armamentarium for infection control and prevention.

Authors:  Aaron M Milstone; Catherine L Passaretti; Trish M Perl
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

Review 8.  Mupirocin resistance.

Authors:  Jean B Patel; Rachel J Gorwitz; John A Jernigan
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

Review 9.  Adverse outcomes associated with Contact Precautions: a review of the literature.

Authors:  Daniel J Morgan; Daniel J Diekema; Kent Sepkowitz; Eli N Perencevich
Journal:  Am J Infect Control       Date:  2009-03       Impact factor: 2.918

10.  Targeted versus universal decolonization to prevent ICU infection.

Authors:  Susan S Huang; Edward Septimus; Ken Kleinman; Julia Moody; Jason Hickok; Taliser R Avery; Julie Lankiewicz; Adrijana Gombosev; Leah Terpstra; Fallon Hartford; Mary K Hayden; John A Jernigan; Robert A Weinstein; Victoria J Fraser; Katherine Haffenreffer; Eric Cui; Rebecca E Kaganov; Karen Lolans; Jonathan B Perlin; Richard Platt
Journal:  N Engl J Med       Date:  2013-05-29       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.